242 related articles for article (PubMed ID: 34903667)
1. Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer.
Kattan WE; Liu J; Montufar-Solis D; Liang H; Brahmendra Barathi B; van der Hoeven R; Zhou Y; Hancock JF
Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34903667
[TBL] [Abstract][Full Text] [Related]
2. Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function.
Kattan WE; Chen W; Ma X; Lan TH; van der Hoeven D; van der Hoeven R; Hancock JF
Life Sci Alliance; 2019 Oct; 2(5):. PubMed ID: 31451509
[TBL] [Abstract][Full Text] [Related]
3. INTRACELLULAR TRANSPORT. PI4P/phosphatidylserine countertransport at ORP5- and ORP8-mediated ER-plasma membrane contacts.
Chung J; Torta F; Masai K; Lucast L; Czapla H; Tanner LB; Narayanaswamy P; Wenk MR; Nakatsu F; De Camilli P
Science; 2015 Jul; 349(6246):428-32. PubMed ID: 26206935
[TBL] [Abstract][Full Text] [Related]
4. PI(4,5)P
Sohn M; Korzeniowski M; Zewe JP; Wills RC; Hammond GRV; Humpolickova J; Vrzal L; Chalupska D; Veverka V; Fairn GD; Boura E; Balla T
J Cell Biol; 2018 May; 217(5):1797-1813. PubMed ID: 29472386
[TBL] [Abstract][Full Text] [Related]
5. ORP5 and ORP8 bind phosphatidylinositol-4, 5-biphosphate (PtdIns(4,5)P
Ghai R; Du X; Wang H; Dong J; Ferguson C; Brown AJ; Parton RG; Wu JW; Yang H
Nat Commun; 2017 Oct; 8(1):757. PubMed ID: 28970484
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity.
Adhikari H; Kattan WE; Kumar S; Zhou P; Hancock JF; Counter CM
Nat Commun; 2021 Sep; 12(1):5248. PubMed ID: 34504076
[TBL] [Abstract][Full Text] [Related]
7. PtdSer as a signaling lipid determined by privileged localization of ORP5 and ORP8 at ER/PM junctional foci to determine PM and ER PtdSer/PI(4)P ratio and cell function.
Chung WY; Ahuja M; McNally BA; Leibow SR; Ohman HKE; Movahed Abtahi A; Muallem S
Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2301410120. PubMed ID: 37607230
[TBL] [Abstract][Full Text] [Related]
8. ORP5/ORP8 localize to endoplasmic reticulum-mitochondria contacts and are involved in mitochondrial function.
Galmes R; Houcine A; van Vliet AR; Agostinis P; Jackson CL; Giordano F
EMBO Rep; 2016 Jun; 17(6):800-10. PubMed ID: 27113756
[TBL] [Abstract][Full Text] [Related]
9. INTRACELLULAR TRANSPORT. Phosphatidylserine transport by ORP/Osh proteins is driven by phosphatidylinositol 4-phosphate.
Moser von Filseck J; Čopič A; Delfosse V; Vanni S; Jackson CL; Bourguet W; Drin G
Science; 2015 Jul; 349(6246):432-6. PubMed ID: 26206936
[TBL] [Abstract][Full Text] [Related]
10. Myotubularin-related proteins regulate KRAS function by controlling plasma membrane levels of polyphosphoinositides and phosphatidylserine.
Henkels KM; Miller TE; Naji A; van der Hoeven R; Liang H; Zhou Y; Hammond GRV; Hancock JF; Cho KJ
bioRxiv; 2024 Jan; ():. PubMed ID: 38328115
[TBL] [Abstract][Full Text] [Related]
11. Acylpeptide hydrolase is a novel regulator of KRAS plasma membrane localization and function.
Tan L; Cho KJ; Kattan WE; Garrido CM; Zhou Y; Neupane P; Capon RJ; Hancock JF
J Cell Sci; 2019 Jul; 132(15):. PubMed ID: 31266814
[TBL] [Abstract][Full Text] [Related]
12. Oxysterol-binding protein-related protein (ORP) 6 localizes to the ER and ER-plasma membrane contact sites and is involved in the turnover of PI4P in cerebellar granule neurons.
Mochizuki S; Miki H; Zhou R; Kido Y; Nishimura W; Kikuchi M; Noda Y
Exp Cell Res; 2018 Sep; 370(2):601-612. PubMed ID: 30028970
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Subverts Human Choline Kinase-α To Bridge Phosphatidylinositol-4-Kinase IIIα (PI4KIIIα) and NS5A and Upregulates PI4KIIIα Activation, Thereby Promoting the Translocation of the Ternary Complex to the Endoplasmic Reticulum for Viral Replication.
Wong MT; Chen SS
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566381
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
[TBL] [Abstract][Full Text] [Related]
15. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
[TBL] [Abstract][Full Text] [Related]
16. A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth.
Pan T; Zhang Y; Zhou N; He X; Chen C; Liang L; Duan X; Lin Y; Wu K; Zhang H
Oncotarget; 2016 Jul; 7(28):44299-44309. PubMed ID: 27322423
[TBL] [Abstract][Full Text] [Related]
17. Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors.
Wang P; van der Hoeven D; Ye N; Chen H; Liu Z; Ma X; Montufar-Solis D; Rehl KM; Cho KJ; Thapa S; Chen W; van der Hoeven R; Frost JA; Hancock JF; Zhou J
Eur J Med Chem; 2021 May; 217():113381. PubMed ID: 33756124
[TBL] [Abstract][Full Text] [Related]
18. Depletion of phosphatidylinositol 4-phosphate at the Golgi translocates K-Ras to mitochondria.
Miller TE; Henkels KM; Huddleston M; Salisbury R; Hussain SM; Sasaki AT; Cho KJ
J Cell Sci; 2019 Aug; 132(16):. PubMed ID: 31331963
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum-plasma membrane contact sites integrate sterol and phospholipid regulation.
Quon E; Sere YY; Chauhan N; Johansen J; Sullivan DP; Dittman JS; Rice WJ; Chan RB; Di Paolo G; Beh CT; Menon AK
PLoS Biol; 2018 May; 16(5):e2003864. PubMed ID: 29782498
[TBL] [Abstract][Full Text] [Related]
20. An assembly of proteins and lipid domains regulates transport of phosphatidylserine to phosphatidylserine decarboxylase 2 in Saccharomyces cerevisiae.
Riekhof WR; Wu WI; Jones JL; Nikrad M; Chan MM; Loewen CJ; Voelker DR
J Biol Chem; 2014 Feb; 289(9):5809-19. PubMed ID: 24366873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
